S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

electroCore Stock Forecast, Price & News

+0.04 (+1.88 %)
(As of 02/26/2021 12:00 AM ET)
Today's Range
Now: $2.17
50-Day Range
MA: $2.42
52-Week Range
Now: $2.17
Volume2.25 million shs
Average Volume2.37 million shs
Market Capitalization$98.64 million
P/E RatioN/A
Dividend YieldN/A
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of patient administered non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.
electroCore logo


electroCore completes enrollment in - Seeking Alpha
February 24, 2021 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Electromedical equipment
Current SymbolNASDAQ:ECOR
Year FoundedN/A



Sales & Book Value

Annual Sales$2.39 million
Book Value$0.84 per share


Net Income$-45,150,000.00
Net Margins-792.01%


Market Cap$98.64 million
Next Earnings Date3/22/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

1.23 out of 5 stars

Medical Sector

809th out of 1,962 stocks

Electromedical Equipment Industry

21st out of 61 stocks

Analyst Opinion: 3.4Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
+0.04 (+1.88 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ECOR News and Ratings via Email

Sign-up to receive the latest news and ratings for ECOR and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

electroCore (NASDAQ:ECOR) Frequently Asked Questions

Is electroCore a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for electroCore in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" electroCore stock.
View analyst ratings for electroCore
or view top-rated stocks.

What stocks does MarketBeat like better than electroCore?

Wall Street analysts have given electroCore a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but electroCore wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting electroCore?

electroCore saw a increase in short interest in January. As of January 29th, there was short interest totaling 811,400 shares, an increase of 78.3% from the January 14th total of 455,000 shares. Based on an average daily volume of 1,480,000 shares, the short-interest ratio is presently 0.5 days.
View electroCore's Short Interest

When is electroCore's next earnings date?

electroCore is scheduled to release its next quarterly earnings announcement on Monday, March 22nd 2021.
View our earnings forecast for electroCore

How were electroCore's earnings last quarter?

electroCore, Inc. (NASDAQ:ECOR) posted its quarterly earnings results on Thursday, November, 12th. The company reported ($0.10) EPS for the quarter, beating analysts' consensus estimates of ($0.12) by $0.02. The business earned $1.08 million during the quarter, compared to analysts' expectations of $1 million. electroCore had a negative trailing twelve-month return on equity of 109.15% and a negative net margin of 792.01%.
View electroCore's earnings history

How has electroCore's stock been impacted by COVID-19?

electroCore's stock was trading at $0.5874 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ECOR stock has increased by 269.4% and is now trading at $2.17.
View which stocks have been most impacted by COVID-19

What guidance has electroCore issued on next quarter's earnings?

electroCore issued an update on its FY 2020 IntraDay earnings guidance on Monday, January, 11th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.5-3.5 million, compared to the consensus revenue estimate of $3.41 million.

What price target have analysts set for ECOR?

6 Wall Street analysts have issued 12 month price objectives for electroCore's stock. Their forecasts range from $2.00 to $5.00. On average, they anticipate electroCore's share price to reach $3.42 in the next year. This suggests a possible upside of 57.5% from the stock's current price.
View analysts' price targets for electroCore
or view top-rated stocks among Wall Street analysts.

Who are electroCore's key executives?

electroCore's management team includes the following people:
  • Mr. Daniel S. Goldberger, CEO & Director (Age 62, Pay $187.5k)
  • Mr. Joseph P. Errico, Co-Founder, Principal Investor & Director (Age 52, Pay $776.28k)
  • Mr. Brian M. Posner, CFO & Corp. Sec. (Age 59, Pay $380.54k)
  • Dr. Peter S. Staats, Chief Medical Officer (Age 57, Pay $238.41k)
  • Mr. Michael Romaniw, Exec. VP of Systems & Operations (Age 64)
  • Ms. Jackie Dorsky, Director of Marketing
  • Ms. Carrie Kochek, Sr. Director of HR
  • Mr. Eric J. Liebler, Sr. VP of Neurology (Age 57)

Who are some of electroCore's key competitors?

What other stocks do shareholders of electroCore own?

Based on aggregate information from My MarketBeat watchlists, some companies that other electroCore investors own include T2 Biosystems (TTOO), Heat Biologics (HTBX), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), Vaxart (VXRT), Bionano Genomics (BNGO), Matinas BioPharma (MTNB), Acasti Pharma (ACST), Onconova Therapeutics (ONTX) and OPKO Health (OPK).

When did electroCore IPO?

(ECOR) raised $64 million in an IPO on Friday, June 22nd 2018. The company issued 4,300,000 shares at $14.00-$16.00 per share. Evercore ISI and JMP Securities acted as the underwriters for the IPO and BTIG was co-manager.

What is electroCore's stock symbol?

electroCore trades on the NASDAQ under the ticker symbol "ECOR."

Who are electroCore's major shareholders?

electroCore's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Valeo Financial Advisors LLC (3.33%), GSA Capital Partners LLP (0.34%), Squarepoint Ops LLC (0.27%), Hussman Strategic Advisors Inc. (0.27%), Renaissance Technologies LLC (0.24%) and Jaffetilchin Investment Partners LLC (0.10%). Company insiders that own electroCore stock include Brian M Posner, James L L Tullis, Joseph P Errico and Thomas J Errico.
View institutional ownership trends for electroCore

Which major investors are selling electroCore stock?

ECOR stock was sold by a variety of institutional investors in the last quarter, including Hussman Strategic Advisors Inc., and Jaffetilchin Investment Partners LLC.
View insider buying and selling activity for electroCore
or view top insider-selling stocks.

Which major investors are buying electroCore stock?

ECOR stock was acquired by a variety of institutional investors in the last quarter, including Valeo Financial Advisors LLC, GSA Capital Partners LLP, Renaissance Technologies LLC, and Squarepoint Ops LLC. Company insiders that have bought electroCore stock in the last two years include Brian M Posner, James L L Tullis, and Thomas J Errico.
View insider buying and selling activity for electroCore
or or view top insider-buying stocks.

How do I buy shares of electroCore?

Shares of ECOR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is electroCore's stock price today?

One share of ECOR stock can currently be purchased for approximately $2.17.

How much money does electroCore make?

electroCore has a market capitalization of $98.64 million and generates $2.39 million in revenue each year. The company earns $-45,150,000.00 in net income (profit) each year or ($1.54) on an earnings per share basis.

How many employees does electroCore have?

electroCore employs 51 workers across the globe.

What is electroCore's official website?

The official website for electroCore is www.electrocore.com.

Where are electroCore's headquarters?

electroCore is headquartered at 150 ALLEN ROAD SUITE 201, BASKING RIDGE NJ, 07920.

How can I contact electroCore?

electroCore's mailing address is 150 ALLEN ROAD SUITE 201, BASKING RIDGE NJ, 07920. The company can be reached via phone at 973-290-0097 or via email at [email protected]

This page was last updated on 2/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.